BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 895002)

  • 1. [Isomerisation and bioavailability of beta- and alpha-acetyldigoxin (author's transl)].
    Rietbrock N; Vöhringer HF; Kuhlmann J; Maertin K
    Klin Wochenschr; 1977 Jul; 55(13):641-6. PubMed ID: 895002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioavailability of beta-acetyldigoxin and digoxin (author's transl)].
    Flasch H
    Klin Wochenschr; 1975 Sep; 53(18):873-7. PubMed ID: 1172599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioavailability of alpha-acetyldigoxin from Card-Hydergin--a fixed combination of Hydergine and acetyldigoxin.
    Klotz U
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):116-8. PubMed ID: 649228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Absolute bioavailability of beta-acetyldigoxin from tablets and drops in healthy subjects].
    Dreyer M; Dammann HG; Endell W; Rudolph M; Iven H
    Arzneimittelforschung; 1992 Mar; 42(3):303-6. PubMed ID: 1497688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of beta-acetyldigoxin after single and repeated doses of tablets and solution.
    Klotz U; Antonin KH; Bieck PR
    Eur J Clin Pharmacol; 1976; 10(6):417-24. PubMed ID: 1001357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fate of orally administered beta-acetyldigoxin in man (author's transl)].
    Flasch H; Schumpelic V; Koch G
    Arzneimittelforschung; 1977; 27(3):656-9. PubMed ID: 577440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of bioavailability and enteral absorption of digoxin, beta-acetyldigoxin and beta-methhyldigoxin. Measurement of cumulative renal excretion after a single application (author's transl)].
    Greeff K; Hafner D; Strobach H; Wirth KE
    Arzneimittelforschung; 1977; 27(12):2358-64. PubMed ID: 580051
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of body weight in treatment with digoxin and digoxin derivatives (author's transl)].
    Schneider J; Ruiz-Torres A
    Dtsch Med Wochenschr; 1977 Jan; 102(4):116-8. PubMed ID: 832590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic studies on fluoro-alpha-acetyl-digoxin (author's transl)].
    Bodem G; Wirth K; Zimmer A
    Arzneimittelforschung; 1978; 28(2):322-5. PubMed ID: 580403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the bioavailability of the individual components from a combination of dilazep and beta-acetyldigoxin (author's transl)].
    Schaumlöffel E; Prignitz R
    Arzneimittelforschung; 1976; 26(12):2208-13. PubMed ID: 1037278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enhanced bioavailability of digoxin from silica matrix formulations (author's transl)].
    Flasch H; Asmussen B; Heinz N
    Arzneimittelforschung; 1978; 28(2):326-30. PubMed ID: 205226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].
    Ochs H; Bodem G; Hahn E; Dengler HJ
    Klin Wochenschr; 1975 May; 53(9):425-9. PubMed ID: 1152354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)].
    Rietbrock N; Alken RG; Ebert W
    Arzneimittelforschung; 1979; 29(11):1742-5. PubMed ID: 583489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of intravenous administration of dilazep, beta-acetyldigoxin and dilazep/beta-acetyldigoxin on myocardial contractility in dogs].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1920-6. PubMed ID: 4480355
    [No Abstract]   [Full Text] [Related]  

  • 18. Digoxin concentration in cerebrospinal fluid-a study carried out after 9 days of treatment of beta-methyldigoxin or beta-acetyldigoxin.
    Bonelli J; Rameis H; Waginger H
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):93-5. PubMed ID: 7228456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic equivalence and inequivalence of chemically identical substances using cardiac glycosides for an example (author's transpl)].
    Rietbrock N
    Arzneimittelforschung; 1976; 26(1A):135-46. PubMed ID: 947193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.